Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder CancerMax Kates, Trinity J. Bivalacqua, Thomas R. Nirschl et al.|Cancer Immunology Research|2017Cited by 77
Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladderLeonardo Oliveira Reis, George J. Netto, Güneş Güner et al.|Human Pathology|2015Cited by 64
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinomaMasamichi Hayashi, Mohammad Obaidul Hoque, Elisa Guida et al.|Science Signaling|2020Cited by 40
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomesNilay Gandhi, Trinity J. Bivalacqua, Alexander S. Baras et al.|Urologic Oncology Seminars and Original Investigations|2015Cited by 39
Androgen deprivation therapy and morbid obesity: Do they share cardiovascular risk through metabolic syndrome?S. Cleffi, Marcos Tobias‐Machado, Ary Serpa Neto et al.|Actas Urológicas Españolas (English Edition)|2011Cited by 18